Back to top

Image: Bigstock

Diversified Healthcare Trust (DHC) is Attracting Investor Attention: Here is What You Should Know

Read MoreHide Full Article

Diversified Healthcare (DHC - Free Report) is one of the stocks most watched by visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Shares of this residential care real estate investment trust have returned -19% over the past month versus the Zacks S&P 500 composite's +2.7% change. The Zacks REIT and Equity Trust - Other industry, to which Diversified Healthcare Trust belongs, has lost 0.7% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate Revisions

Here at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Diversified Healthcare Trust is expected to post earnings of $0.01 per share for the current quarter, representing a year-over-year change of -80%. Over the last 30 days, the Zacks Consensus Estimate has changed -50%.

The consensus earnings estimate of $0.15 for the current fiscal year indicates a year-over-year change of -11.8%. This estimate has changed -16.7% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $0.40 indicates a change of +166.7% from what Diversified Healthcare Trust is expected to report a year ago. Over the past month, the estimate has changed -7%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for Diversified Healthcare Trust.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue Growth

While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

For Diversified Healthcare Trust, the consensus sales estimate for the current quarter of $371.42 million indicates a year-over-year change of +7.3%. For the current and next fiscal years, $1.5 billion and $1.61 billion estimates indicate +6.5% and +7.2% changes, respectively.

Last Reported Results and Surprise History

Diversified Healthcare Trust reported revenues of $361.54 million in the last reported quarter, representing a year-over-year change of +7.3%. EPS of -$0.43 for the same period compares with $0.03 a year ago.

Compared to the Zacks Consensus Estimate of $362.28 million, the reported revenues represent a surprise of -0.21%. The EPS surprise was -40%.

The company could not beat consensus EPS estimates in any of the last four quarters. The company could not beat consensus revenue estimates in any of the last four quarters.


No investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an An is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Diversified Healthcare Trust is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.


The facts discussed here and much other information on might help determine whether or not it's worthwhile paying attention to the market buzz about Diversified Healthcare Trust. However, its Zacks Rank #4 does suggest that it may underperform the broader market in the near term.

See More Zacks Research for These Tickers

Normally $25 each - click below to receive one report FREE:

Diversified Healthcare Trust (DHC) - free report >>

Published in